170 related articles for article (PubMed ID: 10337446)
1. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine.
Harrer G; Schmidt U; Kuhn U; Biller A
Arzneimittelforschung; 1999 Apr; 49(4):289-96. PubMed ID: 10337446
[TBL] [Abstract][Full Text] [Related]
2. [Use of St. John's Wort for depression in primary care - a non-interventional study].
Musselmann B; Rychlik R; Burkart M
MMW Fortschr Med; 2011 Dec; 153 Suppl 4():119-27. PubMed ID: 23964473
[TBL] [Abstract][Full Text] [Related]
3. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
[TBL] [Abstract][Full Text] [Related]
4. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
Friede M; Henneicke von Zepelin HH; Freudenstein J
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S38-41. PubMed ID: 11518073
[TBL] [Abstract][Full Text] [Related]
5. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
Vorbach EU; Arnoldt KH; Hübner WD
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
10. [Highly dosed St. John's wort extract improves quality of life].
Rudolf GA; Zeller K
MMW Fortschr Med; 2004 Aug; 146 Suppl 2():77-80. PubMed ID: 16739363
[TBL] [Abstract][Full Text] [Related]
11. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
Volz HP; Murck H; Kasper S; Möller HJ
Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
[TBL] [Abstract][Full Text] [Related]
13. A hypericum extract in the treatment of depressive symptoms in outpatients: an open study.
Melzer J; Brignoli R; Keck ME; Saller R
Forsch Komplementmed; 2010 Mar; 17(1):7-14. PubMed ID: 20215757
[TBL] [Abstract][Full Text] [Related]
14. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
Röder C; Schaefer M; Leucht S
Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
[TBL] [Abstract][Full Text] [Related]
15. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
16. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
17. St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
[TBL] [Abstract][Full Text] [Related]
18. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
Noorbala AA; Akhondzadeh S; Tahmacebi-Pour N; Jamshidi AH
J Ethnopharmacol; 2005 Feb; 97(2):281-4. PubMed ID: 15707766
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
Schulz V
Phytomedicine; 2002 Jul; 9(5):468-74. PubMed ID: 12222670
[TBL] [Abstract][Full Text] [Related]
20. St. John's Wort. An option for the primary care treatment of depressive patients?
Gupta RK; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):140-8. PubMed ID: 12904978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
